Skip to main content
Intermediate Technical IVT

neurofibromatosis

Pronunciation: new-roh-figh-broh-muh-TOH-sis

A group of genetic disorders causing tumors to grow along nerves and affecting skin pigmentation. The most common types are NF1 and NF2, each with distinct clinical features.

Full Definition

Neurofibromatosis comprises a group of autosomal dominant genetic disorders characterized by the growth of tumors along nerves and various other clinical manifestations affecting skin, bones, and other organ systems. The two main types are neurofibromatosis type 1 (NF1, von Recklinghausen disease) caused by mutations in the NF1 gene, and neurofibromatosis type 2 (NF2) caused by NF2 gene mutations. NF1 is more common and features café-au-lait spots, neurofibromas, Lisch nodules, and potential complications including malignant transformation, learning disabilities, and skeletal abnormalities. NF2 primarily affects the nervous system with bilateral acoustic neuromas (schwannomas), meningiomas, and other central nervous system tumors. Both conditions require multidisciplinary management including regular surveillance for tumor development and screening for associated complications.

Usage

Usage note: Specify type (NF1 or NF2) when known. Avoid outdated term 'elephant man disease.'

In Context

  • "Genetic testing confirmed neurofibromatosis type 1 in this patient with multiple café-au-lait spots and neurofibromas." — Genetics consultation report
  • "MRI surveillance revealed new schwannomas consistent with the patient's neurofibromatosis type 2 diagnosis." — Neuro-oncology follow-up note

Also known as

von Recklinghausen disease NF1 NF2

Contrasted with

normal neural development absence of neurofibromas

Don't confuse with

schwannomatosis multiple schwannomas café-au-lait syndrome

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON